Bupropion versus methylphenidate in the treatment of children with attention‐deficit/hyperactivity disorder: randomized double‐blind study

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Human psychopharmacology

• Publication date

  2012-07-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1002/hup.2242PMID 22806822
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Attention-Deficit Hyperactivity Disorder

  2012cited by this paper
• Advances and considerations in attention-deficit/hyperactivity disorder pharmacotherapy.

  2011cited by this paper
• Bupropion for adults with attention‐deficit hyperactivity disorder: Meta‐analysis of randomized, placebo‐controlled trials

  2011cited by this paper
• Acetyl-L-Carnitine as an Adjunctive Therapy in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Placebo-Controlled Trial

  2011cited by this paper
• Buspirone Versus Methylphenidate in the Treatment of Attention Deficit Hyperactivity Disorder: A Double-Blind and Randomized Trial

  2010cited by this paper
• Ginkgo biloba for Attention-Deficit/Hyperactivity Disorder in children and adolescents: A double blind, randomized controlled trial

  2010cited by this paper
• Amantadine versus methylphenidate in children and adolescents with attention deficit/hyperactivity disorder: a randomized, double‐blind trial

  2010cited by this paper
• Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double‐blind comparison trial

  2010cited by this paper
• A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder.

  2009cited by this paper
• Attention deficit/hyperactivity disorder: a review and update.

  2008cited by this paper
• Effects of Methylphenidate and Bupropion on DHEA-S and Cortisol Plasma Levels in Attention-deficit Hyperactivity Disorder

  2008cited by this paper
• Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: a double blind, randomized clinical trial.

  2008cited by this paper
• The worldwide prevalence of ADHD: a systematic review and metaregression analysis.

  2007cited by this paper
• A randomized, placebo-controlled clinical trial of bupropion for the prevention of smoking in children and adolescents with attention-deficit/hyperactivity disorder.

  2007cited by this paper
• Pharmacotherapy of attention-deficit/hyperactivity disorder: nonstimulant medication approaches

  2007cited by this paper
• Psychometric properties of the Farsi translation of the kiddie schedule for affective disorders and schizophrenia-present and lifetime version

  2006cited by this paper
• ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation

  2006influential reference
• Stimulants: Therapeutic Actions in ADHD

  2006cited by this paper
• Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo.

  2006cited by this paper
• Attention-deficit/hyperactivity disorder: etiology and pharmacotherapy.

  2006cited by this paper
• Bupropion SR in adults with ADHD: a short-term, placebo-controlled trial

  2005cited by this paper
• Bupropion SR for the Treatment of Substance- Abusing Outpatient Adolescents with Attention- Deficit/Hyperactivity Disorder and Mood Disorders

  2005cited by this paper
• Nonstimulant therapies for attention-deficit hyperactivity disorder (ADHD) in children and adults.

  2005cited by this paper
• Bupropion SR in adolescents with comorbid ADHD and nicotine dependence: a pilot study.

  2004cited by this paper
• BMC Psychiatry BioMed Central

  2004cited by this paper
• Efficacy of theophylline compared to methylphenidate for the treatment of attention‐deficit hyperactivity disorder in children and adolescents: a pilot double‐blind randomized trial

  2004cited by this paper
• Nonstimulant treatment of adult attention-deficit/hyperactivity disorder.

  2004cited by this paper
• Non–stimulant medications in the treatment of ADHD

  2004cited by this paper
• Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial.

  2003cited by this paper
• Non-Stimulant Treatment of Attention-Deficit/Hyperactivity Disorder

  2003cited by this paper
• Bupropion Treatment for Cocaine Abuse and Adult Attention-Deficit/Hyperactivity Disorder

  2002cited by this paper
• Bupropion sustained release in adolescents with comorbid attention-deficit/hyperactivity disorder and depression.

  2001cited by this paper
• How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis.

  2001cited by this paper
• A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults.

  2001cited by this paper
• Bupropion SR vs. Methylphenidate vs. Placebo for Attention Deficit Hyperactivity Disorder in Adults

  2001influential reference
• Attention-deficit/hyperactivity disorder: a life-span perspective.

  1998cited by this paper
• An open clinical trial of buspirone in children with attention-deficit/hyperactivity disorder.

  1998cited by this paper
• ADHD through the life span: the role of bupropion in treatment.

  1998cited by this paper
• An open trial of bupropion for ADHD in adolescents with substance use disorders and conduct disorder.

  1998cited by this paper
• An Open Trial of Venlafaxine in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

  1996cited by this paper
• Bupropion hydrochloride in attention deficit disorder with hyperactivity.

  1996influential reference
• Bupropion: a review of its mechanism of antidepressant activity.

  1995influential reference
• Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder.

  1995influential reference
• Placebo-controlled evaluation of Ritalin side effects.

  1993cited by this paper
• Bupropion exacerbates tics in children with attention-deficit hyperactivity disorder and Tourette's syndrome.

  1993cited by this paper
• Case Study: Bupropion Exacerbates Tics in Children with Attention-deficit Hyperactivity Disorder and Tourette's Syndrome

  1993cited by this paper
• A double-blind trial of bupropion in children with attention deficit disorder.

  1987cited by this paper
• A double-blind trial of bupropion in children with attention deficit disorder.

  1987cited by this paper
• Buspirone, a non-benzodiazepine anxiolytic, increases locus coeruleus noradrenergic neuronal activity.

  1982cited by this paper

• The efficacy and safety of antidepressants as alternative treatment of attention-deficit/hyperactivity disorder in pediatric populations

  2025cites this paper
• BUPROPION FOR ADHD: MECHANISMS OF ACTION AND ITS POTENTIAL AS AN ALTERNATIVE TREATMENT — A REVIEW

  2025cites this paper
• A Systems Biology Perspective on Childhood ADHD: Neurochemical Dysregulation, Brain‐Behavior Interactions, and Emerging Therapeutics

  2025cites this paper
• The role of adrenergic neurotransmitter reuptake inhibitors in the ADHD armamentarium

  2024cites this paper
• Efficacy and safety of monoamine reuptake inhibitors in attention deficit hyperactivity disorder: A Bayesian network meta-analysis.

  2024cites this paper
• Use of Bupropion for Attention-Deficit/Hyperactivity Disorder and Depression in Children and Adolescents

  2024cites this paper
• Uso de Bupropiona para Tratamento do Transtorno de Déficit de Atenção/Hiperatividade (TDAH)

  2023cites this paper
• Use of Contrave, Naltrexone with Bupropion, Bupropion, or Naltrexone and Major Adverse Cardiovascular Events: A Systematic Literature Review

  2022cites this paper
• Efficacy and safety of saffron as adjunctive therapy in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled clinical trial

  2022cites this paper
• Dopamine, Immunity, and Disease

  2022cites this paper
• A systematic review of evidence-based interventions for child and adolescent mental health problems in low- and middle-income countries.

  2022cites this paper
• Attention-Deficit/Hyperactivity Disorder.

  2021cites this paper
• Emerging drugs for the treatment of attention-deficit hyperactivity disorder (ADHD)

  2020cites this paper
• Is Experimental Evolution of an Increased Aerobic Exercise Performance in Bank Voles Mediated by Endocannabinoid Signaling Pathway?

  2019cites this paper
• Crocus sativus L. Versus Methylphenidate in Treatment of Children with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Pilot Study

  2019cites this paper
• Efficacy and safety of drugs for attention deficit hyperactivity disorder in children and adolescents: a network meta-analysis

  2018cites this paper
• Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.

  2018cites this paper
• The effect of monoamines reuptake inhibitors on aerobic exercise performance in bank voles from a selection experiment

  2018cites this paper
• Antidepressant drug treatment in Child and adolescent Psychiatry

  2017cites this paper
• Prescription Pattern of Antidepressants for Children and Adolescents in Korea Based on Nationwide Data

  2017cites this paper
• A Systematic Review of the Use of Bupropion for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

  2017cites this paper
• ADHD and the Disruptive Behavior Disorders

  2016cites this paper
• Agomelatine as a Treatment for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Double-Blind, Randomized Clinical Trial

  2016cites this paper
• A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI

  2016cites this paper
• World Workshop on Oral Medicine VI: clinical implications of medication-induced salivary gland dysfunction.

  2015cites this paper
• Antidepressant drug development: Focus on triple monoamine reuptake inhibition

  2015influential citation
• World Workshop on Oral Medicine VI: a systematic review of medication-induced salivary gland dysfunction: prevalence, diagnosis, and treatment

  2015influential citation
• Attention-Deficit/Hyperactivity Disorder

  2014cites this paper
• The Olig Family Member HLH-17 Controls Animal Behavior by Modulating Neurotransmitter Signaling in Caenorhabditis elegans

  2014cites this paper
• Central nervous system stimulants and drugs that suppress appetite

  2014cites this paper
• Managing depression in Parkinson's patients: risk factors and clinical pearls.

  2014cites this paper
• [Narrative review of scales assessing attention-deficit/hyperactivity disorder in children and adolescents].

  2014cites this paper
• A systematic review of randomized controlled trials of bupropion versus methylphenidate in the treatment of attention-deficit/hyperactivity disorder

  2014cites this paper
• Dopamine Signaling in C. elegans Is Mediated in Part by HLH-17-Dependent Regulation of Extracellular Dopamine Levels

  2014cites this paper
• Bupropion in adults with Attention-Deficit/Hyperactivity Disorder: a randomized, double-blind study.

  2014cites this paper
• Background, clinical features and treatment of attention deficit hyperactivity disorder in children

  2013cites this paper
• Weight Considerations in Psychotropic Drug Prescribing and Switching

  2013cites this paper
• Formation of Threohydrobupropion from Bupropion Is Dependent on 11β-Hydroxysteroid Dehydrogenase 1

  2013cites this paper
• Buspirone versus methylphenidate in the treatment of children with attention- deficit/ hyperactivity disorder: randomized double-blind study.

  2012cites this paper